clinical trial · NCT05917041
Exploratory Study of SAT-001 in Treatment of Pediatric Patient With Myopia
S-Alpha Therapeutics, Inc.·N/A·completed·n = 60
Children MyopiaSAT-001(Software as Medical Device)
brief summary
The Purpose of this study is to explore the safety and effectiveness of SAT-001, a medical device for the treatment of myopia in pediatric patient with myopia
started
Mar 5, 2021
primary completion
Apr 19, 2023
completion
Apr 3, 2024
last updated
May 3, 2024
detailed description
Myopic pediatric prevalence rate come to increase rapidly globally. This is a clinical trial to explore the safety and effectiveness of SAT-001(as a Software as Medical Device) developed for the treatment of myopia through suppressing the progress myopia
official title
A Randomised, Open-label, Multicenter, Controlled, Exploratory Study on the Effect and Safety of SAT-001 as a Medical Device in Treatment of Pediatric Patients With Myopia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol